6505--Montelukast NA Chewable Tablets Effective August 09, 2026 to August 08, 2027

The Department of Veterans Affairs (VA) National Acquisition Center is set to issue a Request for Proposal (RFP) for the procurement of Montelukast Sodium Chewable Tablets to support multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This procurement will be unrestricted and will result in a single contract awarded to a responsible offeror who can ensure an uninterrupted supply. The contract will cover a base period of one year with four additional one-year option periods. Distribution of the contracted items will occur through the VA’s and DoD’s Pharmaceutical Prime Vendor Programs. Offerors are required to supply the drug under the exact name appearing on the label with a unique NDC number, and labeling must not be altered or covered. Solicitation number 36E79726R0012 is scheduled to be released electronically around February 17, 2026, with proposals due by March 3, 2026. The NAICS code for this acquisition is 325412, and all related documents and amendments will be available only on SAM.gov. The total estimated annual requirements include various package sizes of Montelukast Sodium Chewable Tablets: 4 mg tablets in 30- and 90-count bottles, and 5 mg tablets in 30-, 90-, and 1000-count bottles, with usage estimates ranging from a few hundred to over 15,000 bottles annually depending on the package size. Interested parties are encouraged to monitor SAM.gov for updates and direct questions to the designated contract specialist, Matthew Poulin.